DRAQ5 and DRAQ7 Nuclear Dye Experimental Operating Procedure
DRAQ5 and DRAQ7 Nuclear Dye Experimental Operating Procedure
1. Overview
1.1 Purpose and Scope of Application
This procedure is intended for the standardized use of the two far-red nuclear dyes DRAQ5 and DRAQ7. It is applicable to live-cell nuclear labeling, dead-cell identification, nuclear counterstaining of fixed samples, and immunofluorescence-associated detection on fluorescence microscopy, confocal microscopy, flow cytometry, and related analytical platforms. The procedure includes two commonly used workflows:
(1) DRAQ5 rapid live-cell nuclear staining workflow;
(2) DRAQ7 dead-cell or fixed/permeabilized sample nuclear staining workflow.
Either workflow may be selected according to the experimental objective. If the study involves both live-cell observation and membrane integrity evaluation, DRAQ5 and DRAQ7 may also be incorporated into the same experimental design as grouped controls or sequential detection modules.
1.2 Principle
(1) DRAQ5 is a far-red fluorescent DNA dye that can cross both the plasma membrane and the nuclear membrane. It is both lipophilic and water-soluble, allowing it to directly enter live cells, fixed cells, and some tissue samples for rapid nuclear labeling. This dye usually does not require washing and is suitable for live-cell real-time observation, automated detection, DNA content analysis, and related applications.
(2) DRAQ7 is a far-red fluorescent DNA dye that is non-permeant to live cells. It primarily enters dead cells, late apoptotic cells, or cells with compromised membrane integrity, and is therefore suitable for live/dead discrimination, cytotoxicity evaluation, and endpoint staining analysis. In fixed and permeabilized samples, DRAQ7 can also be used as a far-red nuclear dye for immunofluorescence-associated detection.
(3) Although both dyes target DNA and emit in the far-red region, their experimental roles are different. DRAQ5 is used for total nuclear labeling, whereas DRAQ7 is more suitable for identifying dead or membrane-compromised cells. In experimental design and result interpretation, the two should be treated separately.
2. Materials and Reagents
2.1 Dyes and Basic Parameters
(1) DRAQ5
① Suitable for nuclear staining of live cells, fixed cells, and some tissue samples.
② Molecular formula: C22H28N4O4.
③ Molecular weight: 412.49.
④ CAS No.: 254098-36-7.
⑤ Ex/Em: 601/699 nm.
(2) DRAQ7
① Suitable for identification of dead cells and membrane-compromised cells, and can also be used for nuclear staining of fixed/permeabilized samples.
② Ex/Em: 633/695-697 nm.
③ Store protected from light at 4°C.
2.2 Buffers and Culture Systems
(1) PBS buffer
① Must be free of sodium azide.
② Used for cell resuspension, washing, and working-solution dilution.
(2) Cell culture medium
① In live-cell experiments, DRAQ5 working solution can be prepared directly in a medium suitable for the target cells.
② Different cell types vary in sensitivity to changes in culture conditions; consistency of the culture system before and after staining is recommended.
2.3 Fixation and Permeabilization Reagents
(1) 4% paraformaldehyde in PBS.
(2) 0.5% Triton X-100 in PBS permeabilization solution.
(3) Immunofluorescence blocking solution and secondary antibody system, if needed.
(1) Suspension cells.
(2) Adherent cells.
(3) Cell coverslips.
(4) Tissue sections.
(5) Fixed and permeabilized endpoint samples.
2.5 Consumables and Instruments
(1) Centrifuge tubes, pipette tips, culture plates, or glass slides.
(2) Fluorescence microscope or confocal microscope.
(3) Flow cytometer.
(4) Light-protective materials for operation.
3. Preparation of Working Solutions and Experimental Conditions
3.1 DRAQ5 Working Solution
(1) It is recommended to dilute DRAQ5 1:1000 in PBS or the appropriate culture medium and prepare it fresh before use.
(2) For live-cell experiments, priority should be given to dilution in the original culture system or a compatible culture medium to minimize fluctuations in cell status.
(3) DRAQ5 can usually be added after completion of other staining procedures, or directly introduced into the cell culture system for live-cell detection.
3.2 DRAQ7 Working Solution
(1) DRAQ7 should be optimized by pilot experiments according to cell type, sample condition, and instrument sensitivity.
(2) A commonly recommended dilution range is 1:15 to 1:200.
(3) In fixed and permeabilized samples, DRAQ7 is usually added as the terminal nuclear staining step after completion of other fluorescence procedures.
3.3 Incubation and Light Protection
(1) Both DRAQ5 and DRAQ7 should be handled under light-protected conditions as much as possible to reduce fluorescence quenching.
(2) Room-temperature staining generally requires 5–30 min. If staining is performed at 37°C, the staining process is markedly accelerated and the incubation time should be shortened accordingly.
(3) Different cell types, sample thicknesses, and fixation states all affect staining kinetics; optimal conditions should therefore be determined by pilot experiments.
3.4 Key Points for Multicolor Experimental Design
(1) Because DRAQ5 has a broad excitation range, it is not recommended for use together with other far-red fluorophores that can also be excited at 488 nm or 633 nm.
(2) DRAQ7 shows absorption within the 488–647 nm range, and is therefore not recommended for simultaneous use with other far-red fluorescent probes that rely on excitation at 488 nm or 633 nm.
(3) In multicolor analysis, green and orange-red probes should preferably be assigned to detection windows well separated from the far-red channel to reduce spectral overlap and compensation burden.
(4) Mounting media containing DAPI, Hoechst 33342, or PI are not suitable as the default supporting mounting scheme in this procedure, in order to avoid introducing additional nuclear staining or live/dead staining signals.
4. Workflow A: DRAQ5 Live-Cell Nuclear Staining
4.1 Experimental Design and Applicable Scenarios
(1) Suitable for real-time live-cell nuclear labeling.
(2) Suitable for rapid endpoint nuclear staining without washing.
(3) Suitable for nuclear localization observation together with GFP and other green fluorescent proteins.
(4) Suitable for DNA content analysis and nuclear labeling in automated imaging workflows.
4.2 Procedure
(1) Preparation of buffer or culture medium
① Prepare PBS free of sodium azide, or prepare the appropriate culture medium according to cell type.
② For live-cell detection, priority is recommended for a culture medium consistent with the original culture environment.
(2) Sample preparation
① For suspension cells, resuspend cells in PBS or culture medium.
② Recommended cell density should not exceed 4×10^5 cells/mL.
③ For adherent cells, cell density may be estimated according to confluence.
④ For tissue sections, sample load may be estimated based on section area and thickness.
(3) Addition of staining solution
① Dilute DRAQ5 at 1:1000.
② Add directly to the cell suspension, adherent-cell culture well, or tissue section surface.
③ Add as evenly as possible to avoid local overconcentration and inconsistent signal.
(4) Incubation
① Mix gently to ensure even distribution of the staining solution.
② Incubate at room temperature for 5–30 min protected from light.
③ If incubated at 37°C, the time is recommended to be shortened to 1–3 min.
④ Because staining speed differs among cell types, further optimization by pilot experiments is recommended.
(5) Detection
① Usually no washing or further treatment is required.
② Detection may be carried out directly by fluorescence microscopy, confocal imaging, or flow cytometry.
4.3 Key Points for Result Interpretation
(1) DRAQ5 produces a rapid and relatively uniform far-red nuclear signal and is suitable as a nuclear localization reference.
(2) Because DRAQ5 can enter live cells, DRAQ5 positivity does not indicate cell death or membrane damage.
(3) If used for DNA content analysis, staining time, cell status, detection parameters, and sample-processing workflow should be kept consistent across groups.
5. Workflow B: DRAQ7 Dead-Cell or Fixed/Permeabilized Sample Nuclear Staining
5.1 Experimental Design and Applicable Scenarios
(1) Suitable for identifying dead cells and cells with compromised membrane integrity.
(2) Suitable for endpoint detection in cytotoxicity experiments.
(3) Suitable for far-red nuclear counterstaining of fixed and permeabilized samples.
(4) Suitable for nuclear staining of fixed samples combined with immunofluorescence.
5.2 Standard Procedure
(1) Buffer preparation
① Prepare PBS buffer free of sodium azide.
(2) Fixation
① Fix cells in 4% paraformaldehyde in PBS at room temperature for 15 min.
(3) Washing
① Wash cells twice with PBS to remove residual fixative.
(4) Permeabilization
① Place cells in 0.5% Triton X-100 in PBS and permeabilize at room temperature for 10 min.
(5) Second washing
① Wash cells twice with PBS.
(6) Optional immunofluorescence step
① Perform standard immunofluorescence staining according to the experimental design.
② It is recommended to add DRAQ7 after completion of the other fluorescence staining steps to reduce signal loss during the workflow.
(7) DRAQ7 staining
① Dilute DRAQ7 to the optimal concentration according to cell type and detection requirements.
② It is recommended to first perform pilot optimization within the range of 1:15 to 1:200.
③ Stain for 5–30 min at room temperature protected from light.
④ If staining is performed at 37°C, the process is usually faster and the time should be shortened appropriately.
(8) Detection
① Far-red channel detection may be performed using a fluorescence microscope, confocal microscope, or flow cytometer.
② Acquisition parameters should be kept consistent across groups for subsequent comparison.
5.3 Principles for Live/Dead Interpretation
(1) In systems that are neither fixed nor permeabilized, DRAQ7 mainly enters dead cells or cells with compromised membrane integrity and can therefore be used for live/dead discrimination.
(2) In fixed and permeabilized samples, DRAQ7 no longer reflects the original membrane-integrity state of the cells, but instead serves mainly as a general nuclear dye.
(3) If the study objective is evaluation of cell death rate, DRAQ7 positivity after fixation and permeabilization should not be directly interpreted as the original death proportion.
6. Optional Expansion Module: Combined Use of DRAQ5 and DRAQ7
6.1 Combined Application Concept
(1) DRAQ5 is used for total nuclear labeling.
(2) DRAQ7 is used for identifying dead or membrane-compromised cells.
(3) Under suitable instrument channel-resolution conditions, information on both total nuclei and damaged nuclei can be obtained separately.
6.2 Application Recommendations
(1) Microscopy imaging
① DRAQ5 can be used to mark the positions of all nuclei.
② DRAQ7 can be used to identify dead or membrane-compromised nuclei.
③ Total nuclear count, DRAQ7-positive nuclear count, and positive ratio can then be further quantified.
(2) Flow cytometric analysis
① First exclude debris and abnormal events.
② After defining the cell population, use the DRAQ7-positive population to define dead or membrane-compromised cells.
③ If DRAQ5 also needs to be used, effective distinction should first be confirmed through instrument optical path and compensation settings.
(3) Technical limitations
① Because both dyes are located in the far-red region, filter configuration, excitation source, and compensation scheme must be confirmed as suitable before combined use.
② If the detection platform has limited far-red channel discrimination capability, it is more appropriate to use DRAQ5 and DRAQ7 separately in different experiments rather than forcing co-staining in the same well.
7. Quality Control Points
7.1 Dye Handling
(1) Avoid repeated freeze-thaw cycles; aliquoted storage is recommended.
(2) Before use, a brief high-speed centrifugation for several seconds is recommended to bring the liquid to the bottom of the tube.
(3) During storage and operation, protect from light as much as possible to reduce fluorescence quenching.
7.2 Sample-State Control
(1) In live-cell experiments, medium replacement, pipetting, centrifugation, and temperature fluctuations may all affect membrane integrity and thereby alter DRAQ7 background signal.
(2) If suspension cell density is too high, dye diffusion may be limited, resulting in uneven signal or cell aggregation during flow cytometry.
(3) If adherent cells are overly confluent, nuclear boundaries may become unclear, affecting imaging segmentation and counting analysis.
7.3 Consistency of Imaging and Detection
(1) Within the same experiment, exposure time, laser power, gain, and threshold settings should be fixed.
(2) Brightness adjustment should not be used to substitute for true signal comparison between groups.
(3) For quantitative analysis, staining time and instrument loading order should be standardized to reduce systematic error caused by temporal drift.
8. Common Problems and Cause Analysis
8.1 Weak DRAQ5 Staining
(1) Excessive dilution of the dye or improper storage conditions.
(2) Incubation time too short, especially under low-temperature conditions where entry into cells is slower.
(3) Cell density too high or tissue samples too thick, causing uneven dye distribution.
(4) Detection parameters in the far-red channel set too low.
8.2 High Background or Uneven DRAQ5 Staining
(1) Inadequate mixing after dye addition.
(2) Uneven liquid-layer thickness in adherent-cell culture wells.
(3) Local evaporation causing dye concentration.
(4) Different imaging conditions between sample edge regions and central regions.
8.3 Abnormally High DRAQ7 Positivity Rate
(1) Additional membrane damage introduced during sample processing, such as overly vigorous pipetting, excessive centrifugation, or temperature stress.
(2) Poor baseline sample condition, with an intrinsically high level of cell death.
(3) Interpreting fixed and permeabilized samples using live/dead logic, resulting in incorrect judgment.
8.4 Obvious Spectral Crosstalk in Multicolor Experiments
(1) Overuse of far-red fluorophores.
(2) Simultaneous use with other far-red fluorescent probes excitable at 488 nm or 633 nm.
(3) Inappropriate filter configuration, compensation settings, or channel-separation strategy.
9. Safety and Operational Standards
9.1 Personal Protection
(1) Laboratory coats and disposable gloves should be worn throughout the experiment.
(2) When handling fixatives, permeabilization solutions, and biological samples, operate according to laboratory safety regulations.
9.2 Waste Disposal
(1) Waste containing cell samples, fixative, or residual dye solutions should be collected separately and disposed of according to regulations.
(2) All operations should comply with institutional biosafety and chemical-management requirements.
10. Product Table Related to DRAQ5 and DRAQ7 Experiments
Catalog No. | Name | Grade and Purity | Corresponding Step / Use |
Ready-to-use DRAQ5 Live Cell DNA Dye (5 mM) | BioReagent, ready to use, biological stain, suitable for fluorescence analysis, for microscope, sterile, 5 mM | Main DRAQ5 dye; used for rapid live-cell nuclear staining, endpoint nuclear staining, and far-red channel imaging | |
Ready-to-use DRAQ7 Dead Cell DNA Dye (0.3 mM) | BioReagent, ready to use, biological stain, suitable for fluorescence analysis, for microscope, sterile, 0.3 mM | Main DRAQ7 dye; used for identifying dead cells or membrane-compromised cells, and also for nuclear staining of fixed/permeabilized samples | |
PBS Buffer,pH7.3-7.5,sterile,does not contain Ca2+/Mg2+ | 1× | For cell resuspension, washing, and preparation of DRAQ5/DRAQ7 working solutions | |
PBS Buffer,pH7.3-7.5,sterile,does not contain Ca2+/Mg2+ | 10× | For preparation of experimental PBS buffer; suitable for batch washing and preparation of dye-dilution systems | |
Paraformaldehyde | ≥95% | Cell fixation step in the DRAQ7 fixation/permeabilization workflow | |
Paraformaldehyde | AR | Cell fixation step in the DRAQ7 fixation/permeabilization workflow | |
Triton™ X-100 | UltraBio™, ultrapure grade | Sample permeabilization after fixation; used for DRAQ7 fixed-sample nuclear staining or immunofluorescence pretreatment | |
Immunostaining Permeabilization Buffer with Triton X-100 | BioReagent, suitable for immunofluorescence (IF), suitable for immunohistochemistry (for IHC), for protein analysis, ready to use, 0.3% | Ready-to-use permeabilization treatment for fixed samples; suitable for standardized pretreatment before DRAQ7 nuclear staining | |
Triton™ X-100 | Biochemical reagent | Sample permeabilization after fixation; suitable for routine nuclear staining or immunofluorescence pretreatment | |
Triton™ X-100 | Biochemical reagent, peroxide value ≤7 meq/kg | Sample permeabilization after fixation; suitable for systems requiring tighter impurity-background control | |
Triton™ X-100 | Molecular biology grade | Sample permeabilization after fixation; suitable for sample processing requiring higher purity background control | |
Bovine Serum Albumin(BSA) | Low endotoxin, protease free, ≥98%, lyophilized | Optional blocking agent in immunofluorescence steps; reduces nonspecific binding background | |
Bovine Serum Albumin(BSA) | Sterile filtered, for cell culture, low endotoxin, 10% in DPBS, fatty acid free | Optional immunofluorescence blocking agent; suitable for cell-sample-related blocking systems | |
Bovine Serum Albumin(BSA) | Low endotoxin, for cell culture, ≥98%, chromatographically purified, New Zealand origin, pH 7 | Optional immunofluorescence blocking agent; suitable for background control in cell samples | |
Bovine Serum Albumin(BSA) | Protease free, low fatty acid, ≥98%, low fatty acid, heat shock fraction, Australia origin, pH 7, low IgG | Optional immunofluorescence blocking agent; suitable for systems with stringent background control requirements | |
Bovine Serum Albumin(BSA) | Heat shock fraction, New Zealand origin, protease free, IgG free, fatty acid free, pH 7.0, ≥98% | Optional immunofluorescence blocking agent; suitable for reducing nonspecific background | |
Enhanced Antifade Mounting Medium | BioReagent, suitable for fluorescence analysis, suitable for immunofluorescence (IF) | Mounting before imaging of fixed samples; reduces far-red fluorescence fading | |
Antifluorescent quencher | — | Mounting before imaging of fixed samples; reduces fluorescence quenching | |
Antifade Mounting Medium | — | Mounting before imaging of fixed samples; helps preserve far-red signal | |
Polyvinyl Alcohol Anti-Fluorescence Quenching Mounting Medium | Suitable for immunofluorescence (IF), BioReagent, for microscope, suitable for fluorescence analysis | Mounting of fixed samples; suitable for microscopic imaging | |
UltraBio™ Secondary Antibody Dilution Buffer for Immunostaining | — | Secondary-antibody preparation and background control in optional immunofluorescence steps | |
UltraBio™ Secondary Antibody Dilution Buffer for Immunofluorescence | — | Secondary-antibody preparation in optional immunofluorescence steps; suitable for use with DRAQ7 nuclear staining in fixed samples | |
Immunostaining Secondary Antibody Dilution Buffer | BioReagent, sterile filtered, ready to use, suitable for immunohistochemistry, suitable for immunofluorescence | Secondary-antibody preparation and workflow standardization in optional immunofluorescence steps |
For more related articles, please see below:
[1] Staining Principles and Methods for Cell Death, Proliferation, and Metabolic Viability